Maximum flow rate--the single uroflowmetric parameter in clinical trials for benign prostatic hyperplasia?

Area of Science:

• Urology
• Medical Diagnostics

Background:

• Assessing uroflowmetry parameter reliability is crucial for benign prostatic hyperplasia (BPH) clinical trials.
• Standardized test conditions are needed for accurate pre- and post-intervention uroflow rate comparisons in BPH patients.

Purpose of the Study:

• To evaluate the reproducibility of maximum flow rate (Qmax) and its modified forms in BPH patients.
• To determine the impact of urinary volume on uroflowmetry test reliability.

Main Methods:

• Examined reproducibility of Qmax and modified uroflow rates in 67 BPH patients.
• Utilized Spearman's correlation coefficient (r) to assess reliability.
• Investigated the effect of urinary volume and bladder instillation on reproducibility.

Main Results:

• Qmax demonstrated higher reproducibility (r=0.672) compared to modified uroflow rates.
• Bladder instillation significantly improved reliability (r=0.811).
• Voided volumes >= 150 ml or a volume ratio < 2.0 enhanced uroflowmetry reproducibility (r=0.690-0.736).

Conclusions:

• Maximum flow rate (Qmax) is the most practical parameter for comparing uroflowmetric tests in BPH treatment.
• Performing uroflowmetry with voided volumes > 150 ml or a volume ratio < 2.0 improves test reliability.
• These findings support Qmax as a key metric in BPH management and clinical research.